White Paper
Drug Solubility and the Need for Speed
A growing number of new chemical entities are highly insoluble, leading to problems with bioavailability. Drug manufacturers therefore have to find ways of improving solubility if the product is to succeed. This also has to be done as quickly and efficiently as possible, with speed of the essence in every drug development program.
This playbook looks at why insolubility is an issue, and the properties that affect solubility.
